These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16634700)

  • 1. Emerging therapies for the treatment and prevention of otitis media.
    Aliphas A; Prufer N; Grundfast KM
    Expert Opin Emerg Drugs; 2006 May; 11(2):251-64. PubMed ID: 16634700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute otitis media in an era of increasing antimicrobial resistance and universal administration of pneumococcal conjugate vaccine.
    Pelton SI
    Pediatr Infect Dis J; 2002 Jun; 21(6):599-604; discussion 613-4. PubMed ID: 12182397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches to otitis media.
    Cohen R; Ovetchkine P; Géhanno P
    Curr Opin Infect Dis; 2001 Jun; 14(3):337-42. PubMed ID: 11964853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of immunization with pneumococcal conjugated vaccines on Streptococcus pneumoniae resistance patterns in acute otitis media.
    Marom T; Avraham E; Cinamon U; Tamir SO
    J Microbiol Immunol Infect; 2017 Oct; 50(5):714-717. PubMed ID: 26507672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children.
    Ubukata K; Morozumi M; Sakuma M; Takata M; Mokuno E; Tajima T; Iwata S;
    Pediatr Infect Dis J; 2018 Jun; 37(6):598-604. PubMed ID: 29474258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otitis media. A scholarly review of the evidence.
    Pappas DE; Owen Hendley J
    Minerva Pediatr; 2003 Oct; 55(5):407-14. PubMed ID: 14608264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine.
    Harrison CJ
    Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S120-30. PubMed ID: 14566998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. treatment and prevention of otitis media.
    Erramouspe J; Heyneman CA
    Ann Pharmacother; 2000 Dec; 34(12):1452-68. PubMed ID: 11144704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.
    Garbutt J; Rosenbloom I; Wu J; Storch GA
    Pediatrics; 2006 Jun; 117(6):e1087-94. PubMed ID: 16740811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of antibiotic resistance for management of acute otitis media.
    Klein JO
    Pediatr Infect Dis J; 1998 Nov; 17(11):1084-9; discussion 1099-100. PubMed ID: 9850003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief review of the clinical effectiveness of PREVENAR against otitis media.
    Fletcher MA; Fritzell B
    Vaccine; 2007 Mar; 25(13):2507-12. PubMed ID: 17011085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Pneumococcal Conjugate Vaccines to Prevent Acute Otitis Media in Children.
    Christie J
    Am J Nurs; 2021 Feb; 121(2):25. PubMed ID: 33497122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and therapeutic changes in otitis with anti-pneumococcal vaccination].
    Baquero-Artigao F
    Rev Esp Quimioter; 2007 Mar; 20(1):122-4. PubMed ID: 17530044
    [No Abstract]   [Full Text] [Related]  

  • 16. Pneumococcal vaccines for preventing otitis media.
    Straetemans M; Sanders EA; Veenhoven RH; Schilder AG; Damoiseaux RA; Zielhuis GA
    Cochrane Database Syst Rev; 2002; (2):CD001480. PubMed ID: 12076412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pneumococcal conjugate vaccine and acute otitis media.
    Damoiseaux RA
    N Engl J Med; 2001 May; 344(22):1719; author reply 1720. PubMed ID: 11386280
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute otitis media in the era of pneumococcal vaccination].
    Baquero-Artigao F; del Castillo F
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):505-9. PubMed ID: 19094865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of acute and recurrent otitis media.
    Pelton S
    Lancet; 2000 Oct; 356(9239):1370-1. PubMed ID: 11052574
    [No Abstract]   [Full Text] [Related]  

  • 20. Early Vaccine-type Pneumococcal Acute Otitis Media Does not Predispose to Subsequent Otitis When Compared With Early Acute Otitis Media Due to Other Bacterial Etiology.
    Palmu AA; Lahdenkari M
    Pediatr Infect Dis J; 2018 Jun; 37(6):592-594. PubMed ID: 29200185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.